Gastrinoma

A GASTRIN-secreting neuroendocrine tumor of the non-beta ISLET CELLS, the GASTRIN-SECRETING CELLS. This type of tumor is primarily located in the PANCREAS or the DUODENUM. Majority of gastrinomas are malignant. They metastasize to the LIVER; LYMPH NODES; and BONE but rarely elsewhere. The presence of gastrinoma is one of three requirements to be met for identification of ZOLLINGER-ELLISON SYNDROME, which sometimes occurs in families with MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; (MEN 1).

Also Known As:

Ulcerogenic Islet Cell Tumor; Gastrin Producing Tumor; Gastrin-Producing Tumors; Gastrinomas; Tumor, Gastrin-Producing; Tumors, Gastrin-Producing; Gastrin-Producing Tumor; Islet Cell Tumor, Ulcerogenic

Neoplasms: 1324753
- Neoplasms by Site: 4
  - Digestive System Neoplasms: 236
    - Pancreatic Neoplasms: 34238
      - Islet Cell Carcinoma: 160
        Gastrinoma: 873
  - Endocrine Gland Neoplasms: 130
    - Pancreatic Neoplasms: 34238
      - Islet Cell Carcinoma: 160
        Gastrinoma: 873
- Neoplasms by Histologic Type: 2
  - Glandular and Epithelial Neoplasms: 439
    - Carcinoma: 141855
      - Adenocarcinoma: 58365
        Islet Cell Carcinoma: 160
        Gastrinoma: 873
Digestive System Diseases: 1042
- Pancreatic Diseases: 1635
  - Pancreatic Neoplasms: 34238
    - Islet Cell Carcinoma: 160
      - Gastrinoma: 873
- Digestive System Neoplasms: 236
  - Pancreatic Neoplasms: 34238
    - Islet Cell Carcinoma: 160
      - Gastrinoma: 873
Endocrine System Diseases: 968
- Endocrine Gland Neoplasms: 130
  - Pancreatic Neoplasms: 34238
    - Islet Cell Carcinoma: 160
      - Gastrinoma: 873

E A Lew Selected Research

E A Lew Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure